Faro Health Inc. Appoints Vivian DeWoskin as Chief Strategy Officer

Vivian DeWoskin has joined Faro Health Inc. as Chief Strategy Officer, aiming to enhance the growth and adoption of its leading SaaS platform for data-driven clinical development.

Faro Health Inc., based in San Diego, announced Vivian's appointment as part of their effort to expand the market presence of their AI-based platform, designed to transform clinical trial protocol development through data-driven and patient-focused decisions. Vivian brings diverse skills and experience from consulting, sales, product strategy, and commercial leadership to her new role.

Vivian's interest in AI and healthcare began during her studies at Princeton University. She later worked at Trinity Life Sciences and served as VP and Head of Strategy at Komodo Health. Most recently, she was Chief Commercial Officer at NeuraLight, a company focusing on neurodegenerative diseases.

Vivian expressed her excitement about joining Faro Health, emphasizing the potential of the platform to optimize and speed up clinical development. She will lead key strategic initiatives and bridge the gap between Faro, its customers, and the market.